Stock Scorecard
Stock Summary for SI-BONE Inc (SIBN) - $12.15 as of 11/20/2024 8:42:16 PM EST
Total Score
12 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for SIBN
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for SIBN
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for SIBN
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for SIBN
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for SIBN (29 out of 90)
Stock Price Rating (Max of 10) | 5 |
Historical Stock Price Rating (Max of 10) | 7 |
Stock Price Trend (Max of 10) | 1 |
Book Value (Max of 10) | 3 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 4 |
Price to Earnings (Max of 10) | 0 |
Latest News for for SIBN
Financial Details for SIBN
Company Overview |
|
---|---|
Ticker | SIBN |
Company Name | SI-BONE Inc |
Country | USA |
Description | SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and internationally. The company is headquartered in Santa Clara, California. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 9/30/2024 |
Next Earnings Date | N/A |
Stock Price History |
|
Last Day Price | 12.15 |
Price 4 Years Ago | 29.90 |
Last Day Price Updated | 11/20/2024 8:42:16 PM EST |
Last Day Volume | 217,144 |
Average Daily Volume | 444,528 |
52-Week High | 21.70 |
52-Week Low | 11.76 |
Last Price to 52 Week Low | 3.32% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 52.46 |
Sector PE | 40.32 |
5-Year Average PE | -16.05 |
Free Cash Flow Ratio | 3.47 |
Industry Free Cash Flow Ratio | 35.05 |
Sector Free Cash Flow Ratio | 27.97 |
Current Ratio Most Recent Quarter | 8.25 |
Total Cash Per Share | 3.50 |
Book Value Per Share Most Recent Quarter | 3.95 |
Price to Book Ratio | 3.28 |
Industry Price to Book Ratio | 5.44 |
Sector Price to Book Ratio | 20.88 |
Price to Sales Ratio Twelve Trailing Months | 3.30 |
Industry Price to Sales Ratio Twelve Trailing Months | 13.48 |
Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
Analyst Buy Ratings | 5 |
Analyst Strong Buy Ratings | 4 |
Share Statistics |
|
Total Shares Outstanding | 41,938,200 |
Market Capitalization | 509,549,130 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 29.25% |
Reported EPS 12 Trailing Months | -0.91 |
Reported EPS Past Year | -0.65 |
Reported EPS Prior Year | -1.14 |
Net Income Twelve Trailing Months | -37,401,000 |
Net Income Past Year | -43,336,000 |
Net Income Prior Year | -61,256,000 |
Quarterly Revenue Growth YOY | 18.60% |
5-Year Revenue Growth | 19.35% |
Operating Margin Twelve Trailing Months | -0.19 |
Balance Sheet |
|
Total Cash Most Recent Quarter | 146,757,000 |
Total Cash Past Year | 156,079,000 |
Total Cash Prior Year | 84,575,000 |
Net Cash Position Most Recent Quarter | 110,565,000 |
Net Cash Position Past Year | 120,014,000 |
Long Term Debt Past Year | 36,065,000 |
Long Term Debt Prior Year | 35,171,000 |
Total Debt Most Recent Quarter | 36,192,000 |
Equity to Debt Ratio Past Year | 0.82 |
Equity to Debt Ratio Most Recent Quarter | 0.82 |
Total Stockholder Equity Past Year | 169,375,000 |
Total Stockholder Equity Prior Year | 98,302,000 |
Total Stockholder Equity Most Recent Quarter | 164,974,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -25,224,000 |
Free Cash Flow Per Share Twelve Trailing Months | -0.60 |
Free Cash Flow Past Year | -26,512,000 |
Free Cash Flow Prior Year | -51,162,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.21 |
MACD Signal | 0.14 |
20-Day Bollinger Lower Band | 11.89 |
20-Day Bollinger Middle Band | 14.58 |
20-Day Bollinger Upper Band | 17.26 |
Beta | 1.23 |
RSI | 43.87 |
50-Day SMA | 16.06 |
150-Day SMA | 17.93 |
200-Day SMA | 20.35 |
System |
|
Modified | 11/19/2024 12:33:57 PM EST |